D.C. Marketplace encourages labs to remove race from kidney function test to advance equity
The Health Insurance Marketplace for the District of Columbia is encouraging labs to remove race as a variable in the estimated glomerular filtration rate (eGFR) formula commonly used to measure kidney function, as recommended by the National Kidney Foundation and American Society of Nephrology to support health equity. The use of race in the equation for eGFR can exacerbate disparities in health outcomes. The D.C. marketplace, known as DC Health Link, covers 100,000 enrollees and 5,300 employers in all 50 states.
Related News Articles
Headline
AHA podcast discusses how telehealth has transformed care for patients at Nantucket Cottage Hospital
In this conversation, Amy Lee, president and chief operating officer at Nantucket Cottage Hospital, shares how telehealth is transforming patient care on the…
Headline
An executive order issued by the White House Oct. 19 directs the Department of Health and Human Services, through the National Institutes of Health, to…
Headline
The second listening session in the AHA’s series on disability health will focus on community partnerships and is scheduled for Oct. 28 at 1 p.m. ET. These…
Headline
In this conversation, Brian Peters, CEO of the Michigan Health & Hospital Association, explores the connection between health disparities, healthcare costs…
Headline
The AHA will host a webinar on Nov. 12 at 2 p.m. ET exploring the AHA’s Economic Impact of Disparities in Health Outcomes Resource Guide which helps hospital…
Headline
Joy A. Rhoden, AHA senior vice president and executive director of health outcomes and care transformation, explores the economic impact of health disparities…